Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Appetite regulation hormones" is not a specific molecule or receptor but rather a broad category encompassing several distinct hormones that regulate hunger and satiety. The most well-characterized members include:\n\n1. Ghrelin: Produced mainly in the stomach, ghrelin stimulates appetite by signaling the hypothalamus when the stomach is empty. It is often called the "hunger hormone"[2][4][6].\n\n2. Leptin: Secreted by adipose tissue, leptin suppresses appetite and signals energy sufficiency to the brain[2][6].\n\n3. Peptide YY (PYY): Released from L-cells in the distal gut after eating, PYY reduces food intake and promotes satiety[1][3][5].\n\n4. Glucagon-like peptide 1 (GLP-1): Also secreted from L-cells postprandially, GLP-1 slows gastric emptying and enhances feelings of fullness; it also has roles in glucose metabolism[1][3][5].\n\n5. Cholecystokinin (CCK): Secreted from I-cells in the small intestine shortly after eating begins; CCK induces early satiation by acting on both neural pathways and direct circulatory routes to suppress food intake[1][7].\n\nOther relevant peptides include insulin (anorexigenic), pancreatic polypeptide, oxyntomodulin, neuropeptide Y (NPY), orexin/hypocretin, melanin-concentrating hormone.\n\nThese hormones act through various receptors—many are G protein–coupled receptors—on neurons within key regions of the hypothalamus such as arcuate nucleus or paraventricular nucleus to modulate feeding behavior[3][8]. Their dysregulation contributes to obesity or other metabolic diseases.\n\nBecause "appetite regulation hormones" refers collectively to multiple molecules with different structures/mechanisms/targets rather than a single defined target entity:\n\n* This entry is not considered a therapeutic target itself, but its individual members are.\n* There are no direct drugs that interact with "appetite regulation hormones" as a group; however, many drugs target individual components such as GLP-1 receptor agonists used in diabetes/obesity therapy.\n* Mechanisms of action vary widely depending on which specific member/receptor/drug pair is considered.\n* Biomarkers/safety concerns must be specified per individual molecule/receptor.\n\nFor structured data purposes you should instead refer individually to each major member—for example “Ghrelin receptor,” “Leptin receptor,” “Glucagon-like peptide 1 receptor,” etc.—to obtain precise information about drug interactions/mechanisms/biomarkers/safety concerns relevant for therapeutic targeting.\n\n> In summary: "Appetite regulation hormones" describes an important physiological system involving multiple distinct molecular targets rather than one canonical molecule or druggable entity[2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Appetite regulation hormone.